Earnings History Data for Deciphera Pharmaceuticals (DCPH) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Deciphera Pharmaceuticals

Deciphera Pharmaceuticals, LLC is a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance. Its drug candidate includes DCC-2618, DCC-3014 and Rebastinib which are in clinical stage. Deciphera Pharmaceuticals, LLC is based in WALTHAM, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
10-05-2024	PM		DCPH	Deciphera Pharmaceuticals	2,086	-0.52	-0.55	0.00		25.34	-0.03 (-0.10%)	25.44	0.07 (0.28%)	9.90 - 25.55	1,640,164	7,250,000	2,082

06-02-2024	PM		DCPH	Deciphera Pharmaceuticals, Inc.	1,160	-0.54	-0.58	-0.60	Deciphera Pharmaceuticals GAAP EPS of -$0.54 beats by $0.04, revenue of $48.3M beats by $1.72M [2/6/2024 7:01 AM]	14.77	0.01 (0.07%)	0.0	0.0 (0.00%)	9.90 - 17.69	610,811	490,000	0
Deciphera Pharmaceuticals Q4 2023 Earnings Preview [2/5/2024 11:00 AM] Deciphera Pharmaceuticals GAAP EPS of -$0.54 beats by $0.04, revenue of $48.3M beats by $1.72M [2/6/2024 7:01 AM]
30-10-2023	PM		DCPH	Deciphera Pharmaceuticals	802.00	-0.58	-0.60	0.00	Deciphera Pharmaceuticals GAAP EPS of -$0.58 beats by $0.03, revenue of $43.31M beats by $4.08M [10/30/2023 7:11 AM]	11.91	1.76 (17.34%)	11.30	1.15 (11.33%)	9.90 - 22.76	3,264,535	560,000	50,509
Deciphera Pharmaceuticals GAAP EPS of -$0.58 beats by $0.03, revenue of $43.31M beats by $4.08M [10/30/2023 7:11 AM] Deciphera stock climbs as trial for tumor therapy succeeds (update) [10/30/2023 2:38 PM]
09-08-2023	PM		DCPH	Deciphera Pharmaceuticals, Inc.	1,010	-0.57	-0.62	-0.60	Deciphera Pharmaceuticals GAAP EPS of -$0.57 beats by $0.05, revenue of $38.3M beats by $1.98M [8/9/2023 7:28 AM]	13.72	0.78 (6.03%)	0.0	0.0 (0.00%)	12.73 - 22.76	275,297	340,000	0
Deciphera Pharmaceuticals Q2 2023 Earnings Preview [8/8/2023 1:56 PM] Deciphera Pharmaceuticals GAAP EPS of -$0.57 beats by $0.05, revenue of $38.3M beats by $1.98M [8/9/2023 7:28 AM]
03-05-2023	PM	7:00 AM ET (May 3)	DCPH	Deciphera Pharmaceuticals, Inc.	1,100	-0.60	-0.60	-0.80	Deciphera Pharmaceuticals GAAP EPS of -$0.60 misses by $0.01, revenue of $33.45M misses by $2.05M [5/3/2023 7:25 AM]	13.91	-0.39 (-2.73%)	14.58	0.28 (1.96%)	9.01 - 22.76	943,577	520,000	228
Deciphera Pharmaceuticals Q1 2023 Earnings Preview [5/2/2023 1:12 PM] Deciphera Pharmaceuticals GAAP EPS of -$0.60 misses by $0.01, revenue of $33.45M misses by $2.05M [5/3/2023 7:25 AM]
07-02-2023	PM	7:00 AM ET (Feb 7)	DCPH	Deciphera Pharmaceuticals, Inc.	1,330	-0.60	-0.57	-1.51	Deciphera Pharmaceuticals GAAP EPS of -$0.60 misses by $0.04, revenue of $36.35M beats by $0.47M [2/7/2023 7:02 AM]	16.59	-0.12 (-0.72%)	17.10	0.39 (2.33%)	6.51 - 22.76	520,696	760,000	11,845
Deciphera Pharmaceuticals GAAP EPS of -$0.60 misses by $0.04, revenue of $36.35M beats by $0.47M [2/7/2023 7:02 AM]
03-11-2022	PM	7:00 AM ET (Nov 3)	DCPH	Deciphera Pharmaceuticals, Inc.	1,120	-0.55	-0.57	-1.37	Deciphera Pharmaceuticals GAAP EPS of -$0.55 beats by $0.03, revenue of $35.97M beats by $2.96M [11/3/2022 7:06 AM]	16.46	-0.18 (-1.05%)	16.64	0.0 (0.00%)	6.51 - 37.99	514,869	460,000	17,904
Deciphera Pharmaceuticals GAAP EPS of -$0.55 beats by $0.03, revenue of $35.97M beats by $2.96M [11/3/2022 7:06 AM]
04-08-2022	PM	7:00 AM ET (Aug 4)	DCPH	Deciphera Pharmaceuticals, Inc.	861.48	-0.60	-0.65	-1.21	Deciphera Pharmaceuticals GAAP EPS of -$0.60 beats by $0.06, revenue of $32.5M beats by $2.39M [8/4/2022 7:22 AM]	16.88	3.31 (24.36%)	13.47	-0.10 (-0.74%)	6.51 - 37.99	1,411,260	600,000	1,436
Deciphera Pharmaceuticals Q2 2022 Earnings Preview [8/3/2022 2:29 PM] Deciphera Pharmaceuticals GAAP EPS of -$0.60 beats by $0.06, revenue of $32.5M beats by $2.39M [8/4/2022 7:22 AM] Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results [Aug-04-22 07:00AM]
08-02-2022	AH	4:00 PM ET (Feb 8)	DCPH	Deciphera Pharmaceuticals, Inc.	460.24	-1.51	-1.49	-1.10	Deciphera Pharmaceuticals GAAP EPS of -$1.51 misses by $0.03, revenue of $24.2M beats by $0.92M [2/8/2022 4:20 PM]	9.39	1.23 (15.07%)	8.42	0.26 (3.19%)	7.36 - 52.35	1,965,782	1,330,000	813
Deciphera Pharmaceuticals GAAP EPS of -$1.51 misses by $0.03, revenue of $24.2M beats by $0.92M [2/8/2022 4:20 PM] Drug/Biotech Stock Q4 Earnings Due Feb 8: PFE, INCY & DCPH [Feb-07-22 09:53AM] CIBC Asset Management Inc Buys Bank of Nova Scotia, Franco-Nevada Corp, Suncor Energy Inc, ... [Feb-08-22 01:38PM] Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2021 Financial Results [Feb-08-22 04:05PM] Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q4 Loss, Tops Revenue Estimates [Feb-08-22 05:15PM] Deciphera (DCPH) Q4 Loss Wider Than Expected, Revenues Beat [Feb-09-22 12:01PM]
02-11-2021	AH	4:00 PM ET (Nov 2)	DCPH	Deciphera Pharmaceuticals, Inc.	2,000	-1.37	-1.29	-1.13	Deciphera Pharmaceuticals EPS misses by $0.09, misses on revenue [11/2/2021 4:12 PM]	37.12	2.02 (5.75%)	35.10	0.0 (0.00%)	26.20 - 68.40	870,016	400,000	18,094
Deciphera Pharmaceuticals EPS misses by $0.09, misses on revenue [11/2/2021 4:12 PM] Deciphera Pharmaceuticals, Inc. Announces Third Quarter 2021 Financial Results [Nov-02-21 04:01PM] Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q3 Loss, Misses Revenue Estimates [Nov-02-21 05:15PM] Deciphera Pharmaceuticals, inc (DCPH) Q3 2021 Earnings Call Transcript [Nov-03-21 12:30AM] Deciphera (DCPH) Q3 Loss Wider Than Expected, Revenues Miss [Nov-03-21 11:05AM]
03-08-2021	AH	4:20 PM ET (Aug 3)	DCPH	Deciphera Pharmaceuticals, Inc.	1,770	-1.21	-1.15	-1.20	Deciphera Pharmaceuticals EPS misses by $0.06, beats on revenue [8/3/2021 4:49 PM]	32.66	3.14 (10.64%)	29.52	0.0 (0.00%)	28.74 - 68.40	1,030,716	290,000	6,185
Deciphera Pharmaceuticals EPS misses by $0.06, beats on revenue [8/3/2021 4:49 PM] Deciphera Pharmaceuticals, Inc. Announces Second Quarter 2021 Financial Results [Aug-03-21 04:01PM] Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q2 Loss, Tops Revenue Estimates [Aug-03-21 05:15PM] Deciphera Pharmaceuticals, inc (DCPH) Q2 2021 Earnings Call Transcript [Aug-04-21 08:01AM] Deciphera (DCPH) Q2 Loss Wider Than Expected, Revenues Beat [Aug-04-21 09:07AM]
04-05-2021	AH	4:00 PM ET (May 4)	DCPH	Deciphera Pharmaceuticals, Inc.	2,700	-1.06	-1.09	-1.36	Deciphera Pharmaceuticals EPS beats by $0.01, beats on revenue [5/4/2021 4:24 PM]	37.17	-6.12 (-14.14%)	41.76	-1.53 (-3.53%)	36.05 - 68.40	1,717,640	330,000	5,165
Deciphera Pharmaceuticals EPS beats by $0.01, beats on revenue [5/4/2021 4:24 PM] Deciphera Pharmaceuticals, Inc. to Host Earnings Call [May-04-21 02:30PM] Deciphera Pharmaceuticals, Inc. Announces First Quarter 2021 Financial Results [May-04-21 04:22PM] Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q1 Loss, Tops Revenue Estimates [May-04-21 05:55PM] Deciphera Pharmaceuticals, Inc. (DCPH) Q1 2021 Earnings Call Transcript [May-05-21 07:30AM] Deciphera (DCPH) Q1 Loss Narrower Than Expected, Revenues Beat [May-05-21 11:54AM]
09-02-2021	AH	4:00 PM ET (Feb 9)	DCPH	Deciphera Pharmaceuticals, Inc.	2,920	-1.10	-1.15	-1.31	Deciphera Pharmaceuticals EPS beats by $0.07, beats on revenue [2/9/2021 4:36 PM]	50.29	1.97 (4.08%)	51.75	3.43 (7.10%)	33.10 - 71.11	1,100,217	502,015	9,513
Deciphera Pharmaceuticals EPS beats by $0.07, beats on revenue [2/9/2021 4:36 PM] Deciphera upgraded by SVB Leerink noting share price weakness [2/10/2021 2:22 PM] Deciphera (DCPH) Reports Narrower-Than-Expected Q4 Loss [Feb-10-21 10:21AM] Deciphera Pharmaceuticals, Inc. (DCPH) Reports Q4 Loss, Tops Revenue Estimates [Feb-09-21 05:15PM] Deciphera Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2020 Financial Results [Feb-09-21 04:01PM] Deciphera Pharmaceuticals, Inc. to Host Earnings Call [Feb-09-21 02:30PM]
05-11-2020	AH	4:05 PM ET (Nov 5)	DCPH	Deciphera Pharmaceuticals, Inc.	3,420	-1.13	-1.32	-1.28	Deciphera Pharmaceuticals EPS beats by $0.18, beats on revenue [11/5/2020 4:34 PM]	60.40	-4.54 (-6.98%)	65.85	0.91 (1.40%)	33.10 - 71.11	470,486	271,144	189

04-08-2020	AH	4:00 PM ET (Aug 4)	DCPH	Deciphera Pharmaceuticals, Inc.	2,590	-1.20	-1.34	-0.56	Deciphera Pharmaceuticals EPS beats by $0.17, beats on revenue [8/4/2020 4:26 PM]	48.82	0.29 (0.60%)	49.11	0.58 (1.20%)	19.88 - 71.11	279,005	372,926	181

05-05-2020	AH	4:00 PM ET (May 5)	DCPH	Deciphera Pharmaceuticals, Inc.	2,920	-1.36	-1.28	-1.25	Deciphera Pharmaceuticals EPS misses by $0.05, misses on revenue [5/5/2020 4:05 PM]	57.15	0.89 (1.58%)	0.0	0.0 (0.00%)	19.88 - 71.11	384,450	615,102	0